ArticleHepatology (Baltimore, Md.)2019

Letter to the Editor: Is Emricasan (IDN-6556), an Oral Pan-Caspase Inhibitor, Ready for Controlled Trials?

Sandeep Khurana et al.PubMed ↗Publisher ↗

No numbers read from the abstract.